Investors' Chronicle cover image

The Companies and Markets show: Centrica, luxury goods, SJP and GSK

Investors' Chronicle

00:00

The Zantac Overhang and the Lack of Share Price Movement

The Zantac issue, the overhang. I think there are signs that this is moving in a decent direction for GSK. The size of this legal action is obviously massive. It's very difficult to say with any real confidence how this is going to go. But again, things are moving or appear to have moved in the right way.

Transcript
Play full episode

The AI-powered Podcast Player

Save insights by tapping your headphones, chat with episodes, discover the best highlights - and more!
App store bannerPlay store banner
Get the app